Review
doi: 10.1016/0002-8703(88)90138-x.
Safety profile of celiprolol
Affiliations
- PMID: 2903657
- DOI: 10.1016/0002-8703(88)90138-x
Item in Clipboard
Review
Safety profile of celiprolol
Am Heart J.
1988 Nov.
Abstract
Celiprolol hydrochloride is a highly cardioselective beta1-adrenergic antagonist with a unique pharmacologic profile. The adverse experience safety data derived from 18 double-blind trials (n = 2884) were evaluated. The results demonstrated a wide margin of safety for celiprolol over the recommended dosage range of 200 to 600 mg once daily. Celiprolol exhibited an adverse experience profile similar to that of placebo and resulted in a lower incidence of bradycardia and age-associated increases in adverse event rates compared with atenolol and propranolol.
Similar articles
-
Celiprolol in angina pectoris.Am Heart J. 1988 Nov;116(5 Pt 2):1422-5. doi: 10.1016/0002-8703(88)90134-2. Am Heart J. 1988. PMID: 2903653 Review.
-
Atenolol and celiprolol for stable angina pectoris.Am J Cardiol. 1988 Feb 10;61(5):52C. doi: 10.1016/0002-9149(88)90486-9. Am J Cardiol. 1988. PMID: 2893533 Clinical Trial.
-
Celiprolol and atenolol in angina--effects on left ventricular function.J Int Med Res. 1988;16 Suppl 1:47A-51A. J Int Med Res. 1988. PMID: 2906017 Clinical Trial.
-
Celiprolol--overview of 6 years of clinical trials experience.J Int Med Res. 1988;16 Suppl 1:17A-22A. J Int Med Res. 1988. PMID: 2906015 Clinical Trial.
-
Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease.Drugs. 1991 Jun;41(6):941-69. doi: 10.2165/00003495-199141060-00009. Drugs. 1991. PMID: 1715268 Review.
Cited by
-
Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.Drugs Aging. 1995 Nov;7(5):394-411. doi: 10.2165/00002512-199507050-00006. Drugs Aging. 1995. PMID: 8573993 Review.
-
Efficacy of celiprolol in hypertension and angina pectoris. Introduction.Cardiovasc Drugs Ther. 1991 Jan;4 Suppl 6:1195-6. doi: 10.1007/BF00114218. Cardiovasc Drugs Ther. 1991. PMID: 1672600 Review. No abstract available.
-
A risk-benefit assessment of celiprolol in the treatment of cardiovascular disease.Drug Saf. 1994 Mar;10(3):220-32. doi: 10.2165/00002018-199410030-00004. Drug Saf. 1994. PMID: 7913813 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
